Brief: Heidelberg Pharma FY Net Loss At EUR 11.0 Million

Heidelberg Pharma AG

22/03/2018 06:22

March 22 (Reuters) - HEIDELBERG PHARMA AG  WL6G.DE :
    * FY FINANCIALS IN LINE WITH GUIDANCE ON BACK OF POSITIVE
REVENUE
PERFORMANCE
    * FY SALES REVENUE OF EUR 1.9 MILLION (PREVIOUS YEAR: EUR
1.3
MILLION
    * FY OPERATING RESULT WAS EUR -10.8 MILLION IN 2017 FISCAL
YEAR
(PREVIOUS YEAR: EUR -6.4 MILLION)
    * FY NET LOSS FOR YEAR WAS EUR 11.0 MILLION (PREVIOUS YEAR:
EUR
6.4 MILLION)
    * OUTLOOK 2018: EXPECTS TO GENERATE BETWEEN EUR 3.0 MILLION
AND
EUR 5.0 MILLION IN SALES REVENUE AND OTHER INCOME
    * OUTLOOK 2018: EBIT PROJECTED TO BE BETWEEN EUR -12.0
MILLION AND
EUR -16.0 MILLION
    * OUTLOOK 2018: EXPECTS TO REQUIRE FUNDS OF EUR 13.0 MILLION
TO
EUR 17.0 MILLION

Source text for Eikon:  ID:nEQ3sFQcfa 
Further company coverage:  WL6G.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))